Edvardsen; Klaus

Patent Applications and Registrations

Patent applications and USPTO patent grants for Edvardsen; Klaus.The latest application filed is for "novel methods and antibodies for treating cancer".

Company Profile

0.12.13

Edvardsen; Klaus - Klampenborg DK
Edvardsen; Klaus - Lund SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and antibodies for treating cancer Grant 9,540,450 - Van De Winkel , et al. January 10, 2	2017-01-10
Method of treating rash in patients undergoing anti-EGFR therapy Grant 9,428,582 - Edvardsen , et al. August 30, 2	2016-08-30
Functionalized stilbene derivatives as improved vascular targeting agents Grant RE45,907 - Chaplin , et al. March 1, 2	2016-03-01
Functionalized stilbene derivatives as improved vascular targeting agents Grant RE45,720 - Chaplin , et al. October 6, 2	2015-10-06
Novel Methods And Antibodies For Treating Cancer App 20140348833 - VAN DE WINKEL; Jan ; et al.	2014-11-27
Compositions and methods with enhanced therapeutic activity Grant 8,198,302 - Chaplin , et al. June 12, 2	2012-06-12
Novel Methods And Antibodies For Treating Cancer App 20110256142 - Van De Winkel; Jan ; et al.	2011-10-20
Prevention Of Rash In Patients Undergoing Anti-egfr Therapy App 20100150936 - Edvardsen; Klaus ; et al.	2010-06-17
Methods for Modulating Tumor Growth and Metastasis App 20090258937 - Lee; Francis Y. ; et al.	2009-10-15
Chromene-containing compounds with anti-tubulin and vascular targeting activity Grant 7,456,214 - Pinney , et al. November 25, 2	2008-11-25
Functionalized stilbene derivatives as improved vascular targeting agents Grant 7,384,925 - Chaplin , et al. June 10, 2	2008-06-10
Tubulin binding ligands and corresponding prodrug constructs Grant 7,091,240 - Pinney , et al. August 15, 2	2006-08-15
Tubulin binding agents and corresponding prodrug constructs Grant 7,001,926 - Pinney , et al. February 21, 2	2006-02-21
Functionalized stilbene derivatives as improved vascular targeting agents App 20060035868 - Chaplin; David J. ; et al.	2006-02-16
Chromene-containing compounds with anti-tubulin and vascular targeting activity App 20050245490 - Pinney, Kevin G. ; et al.	2005-11-03
Chromene-containing compounds with anti-tubulin and vascular targeting activity App 20050245489 - Pinney, Kevin G. ; et al.	2005-11-03
Methods for modulating tumor growth and metastasis App 20050209310 - Chaplin, David J. ; et al.	2005-09-22
Functionalized stilbene derivatives as improved vascular targeting agents Grant 6,919,324 - Chaplin , et al. July 19, 2	2005-07-19
Compositions and methods with enhanced therapeutic activity App 20040242696 - Chaplin, David J. ; et al.	2004-12-02
Use of combretastatin A4 and its prodrugs as an immune enhancing therapy Grant 6,773,702 - Pero , et al. August 10, 2	2004-08-10
Tubulin binding agents and corresponding prodrug constructs App 20040043969 - Pinney, Kevin G. ; et al.	2004-03-04
Tubulin binding ligands and corresponding prodrug constructs App 20040044059 - Pinney, Kevin G. ; et al.	2004-03-04
Functionalized stilbene derivatives as improved vascular targeting agents App 20030149003 - Chaplin, David J. ; et al.	2003-08-07
Use of combretastatin A4 and its prodrugs as an immune enhancing therapy App 20020160973 - Pero, Ronald W. ; et al.	2002-10-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.